Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jing-Li Zhuang
rhTPO Combined With Chemotherapy and G-CSF for Autologous Peripheral Blood Stem Cells in Patients With Refractory/Relapsed Non-Hodgkin’s Lymphoma
Cancer Management and Research
Oncology
Antiangiogenic Drugs Synergize With a Membrane Macrophage Colony-Stimulating Factor-Based Tumor Vaccine to Therapeutically Treat Rats With an Established Malignant Intracranial Glioma
Journal of Immunology
Allergy
Immunology
Related publications
Cyclophosphamide, Etoposide and G-CSF to Mobilize Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Patients With Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Ulcerative Colitis After Autologous Peripheral Blood Stem Cell Transplantation for Non-Hodgkin’s Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Acute Disseminated Encephalomyelitis (ADEM) After Autologous Peripheral Blood Stem Cell Transplant for Non-Hodgkin’s Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Crescentic Glomerulonephritis Developing 3 Months After Autologous Peripheral Blood Stem Cell Transplantation for Non-Hodgkin’s Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Outcome of Patients With Relapsed and Refractory Peripheral T Cell Lymphoma Intended for Stem Cell Transplant
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Peripheral Blood Stem Cell Transplantation in Children and Adolescents With Non‑Hodgkin Lymphoma
Oncology Letters
Cancer Research
Oncology
The Treatment of Relapsed or Refractory Intermediate Grade Non-Hodgkin’s Lymphoma With Autologous Bone Marrow Transplantation Followed by Cyclosporine and Interferon
Bone Marrow Transplantation
Transplantation
Hematology
Rituximab Used in Three Cases With Relapsed Non-Hodgkin’s Lymphoma
Molecular and Clinical Oncology
Cancer Research
Oncology
